Invasive Fungal Infections in Patients with Myeloma in the Era of Novel Myeloma Agents

Autor: Teh, BW, Teng, JC, Urbancic, K, Grigg, A, Harrison, SJ, Worth, LJ, Slavin, MA, Thursky, KA

Publikováno v: 18th Symposium on Infections in the Immunocompromised Host; 20140615-20140617; Berlin; DOC14ichs11 /20140603/

Introduction: Infections are a leading cause of morbidity and mortality in patients with multiple myeloma (MM). The epidemiology and outcomes of invasive fungal infection (IFI) in patients with myeloma remains undefined in the era of novel anti-myelo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b66466f67b1d13556a6299f8d5fa40e

Infections during novel myeloma therapies.

Autor: Liu AJ; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Parkville, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia.; Department of Oncology, The University of Melbourne, Melbourne, Australia., Slavin MA; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Parkville, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia.; Department of Oncology, The University of Melbourne, Melbourne, Australia., Harrison SJ; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia.; Department of Oncology, The University of Melbourne, Melbourne, Australia.; Department of Clinical Haematology, Peter MacCallum Cancer Centre and Royal Melbourne Hospital, Melbourne, Australia., Teh BW; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Parkville, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Australia.; Department of Oncology, The University of Melbourne, Melbourne, Australia.

Publikováno v: Leukemia & lymphoma [Leuk Lymphoma] 2024 Nov 18, pp. 1-13. Date of Electronic Publication: 2024 Nov 18.

Chimeric antigen receptor-T-cell therapies going viral: latent and incidental viral infections.

Autor: Kampouri E; Infectious Diseases Service, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Reynolds G; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne., Teh BW; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne.; Sir Peter MacCallum Department of Oncology, University of Melbourne, Parkville.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia., Hill JA; Vaccine and Infectious Disease Division.; Clinical Research Division, Fred Hutchinson Cancer Center.; Department of Medicine, University of Washington, Seattle, Washington, USA.

Publikováno v: Current opinion in infectious diseases [Curr Opin Infect Dis] 2024 Dec 01; Vol. 37 (6), pp. 526-535. Date of Electronic Publication: 2024 Oct 03.

Infections in patients with lymphoma treated with bispecific antibodies: a systematic review and meta-analysis.

Autor: Reynolds GK; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Department of Infectious Diseases, Austin Health, Melbourne, VIC, Australia., Maclean M; Department of Clinical Hematology, Austin Health, Melbourne, VIC, Australia., Cliff ERS; Program on Regulation, Therapeutics, and Law, Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Teh BW; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Thursky KA; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Slavin MA; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia.; Sir Peter MacCallum Department of Oncology, The University of Melbourne, Parkville, VIC, Australia.; National Centre for Infections in Cancer, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia., Anderson MA; Department of Clinical Hematology, Peter MacCallum Cancer Centre and The Royal Melbourne Hospital, Melbourne, VIC, Australia.; Division of Blood Cells and Blood Cancer, Walter and Eliza Hall Institute, Melbourne, VIC, Australia., Hawkes EA; Department of Clinical Hematology, Austin Health, Melbourne, VIC, Australia.; Olivia Newton John Cancer Research Centre, Austin Health, Melbourne, VIC, Australia.; Monash University School of Public Health and Preventive Medicine, Melbourne, VIC, Australia.

Publikováno v: Blood advances [Blood Adv] 2024 Jul 09; Vol. 8 (13), pp. 3555-3559.

Consensus position statement on advancing the standardised reporting of infection events in immunocompromised patients.

Autor: Teh BW; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, VIC, Australia. Electronic address: ben.teh@petermac.org., Mikulska M; Division of Infectious Diseases, Department of Health Sciences, University of Genoa, Genoa, Italy; IRCCS Ospedale Policlinico San Martino, Genoa, Italy., Averbuch D; Pediatric Infectious Diseases, Faculty of Medicine, Hebrew University of Jerusalem, Jerusalem, Israel; Hadassah Medical Center, Jerusalem, Israel., de la Camara R; Department of Haematology, Hospital de la Princesa, Madrid, Spain., Hirsch HH; Transplantation & Clinical Virology, Department of Biomedicine, University of Basel, Basel, Switzerland; Infectious Diseases & Hospital Epidemiology, University Hospital Basel, Basel, Switzerland., Akova M; Department of Infectious Diseases, Hacettepe University School of Medicine, Ankara, Turkey., Ostrosky-Zeichner L; Division of Infectious Diseases, McGovern Medical School, University of Texas, Houston, TX, USA., Baddley JW; Department of Medicine, Division of Infectious Diseases, University of Maryland School of Medicine, Baltimore, MD, USA., Tan BH; Department of Infectious Diseases, Singapore General Hospital, Singapore., Mularoni A; Department of Infectious Diseases, Istituto Mediterraneo per i Trapianti e Terapie ad Alta Specializzazione (IRCCS), Palermo, Italy., Subramanian AK; Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA, USA., La Hoz RM; Division of Infectious Diseases and Geographic Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA., Marinelli T; Department of Infectious Diseases, Royal Prince Alfred Hospital, Sydney, NSW, Australia., Boan P; Department of Infectious Diseases, Fiona Stanley Hospital, Murdoch, WA, Australia; Department of Microbiology, PathWest Laboratory Medicine WA, Fiona Stanley Hospital, Murdoch, WA, Australia., Aguado JM; Unit of Infectious Diseases, Hospital Universitario '12 de Octubre', Instituto de Investigación Sanitaria Hospital '12 de Octubre' (imas12), CIBERINFEC, Universidad Complutense, Madrid, Spain., Grossi PA; Infectious and Tropical Diseases Unit, Department of Medicine and Surgery, University of Insubria-ASST-Sette Laghi, Varese, Italy., Maertens J; Department of Haematology, Universitaire Ziekenhuizen Leuven, Leuven, Belgium., Mueller NJ; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zürich, Switzerland., Slavin MA; Department of Infectious Diseases, Peter MacCallum Cancer Centre, Melbourne, VIC, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, VIC, Australia; Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, VIC, Australia.

Publikováno v: The Lancet. Infectious diseases [Lancet Infect Dis] 2024 Jan; Vol. 24 (1), pp. e59-e68. Date of Electronic Publication: 2023 Sep 06.